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Abstract
Background: In contrast to many other organisms, the malarial parasite Plasmodium falciparum
possesses only one typical glutathione S-transferase. This enzyme, PfGST, cannot be assigned to any
of the known GST classes and represents a most interesting target for antimalarial drug
development. The PfGST under native conditions forms non-covalently linked higher aggregates
with major population (~98%) being tetramer. However, in the presence of 2 mM GSH, a dimer of
PfGST is observed. Recently reported study on binding and catalytic properties of PfGST indicated
a GSH dependent low-high affinity transition with simultaneous binding of two GSH molecules to
PfGST dimer suggesting that GSH binds to low affinity inactive enzyme dimer converting it to high
affinity functionally active dimer. In order to understand the role of GSH in tetramer-dimer
transition of PfGST as well as in modulation of functional activity of the enzyme, detailed structural,
functional and stability studies on recombinant PfGST in the presence and absence of GSH were
carried out.
Results: Our data indicate that the dimer – and not the tetramer – is the active form of PfGST,
and that substrate saturation is directly paralleled by dissociation of the tetramer. Furthermore,
this dissociation is a reversible process indicating that the tetramer-dimer equilibrium of PfGST is
defined by the surrounding GSH concentration. Equilibrium denaturation studies show that the
PfGST tetramer has significantly higher stability compared to the dimer. The enhanced stability of
the tetramer is likely to be due to stronger ionic interactions existing in it.
Conclusion: This is the first report for any GST where an alteration in oligomeric structure and
not just small conformational change is observed upon GSH binding to the enzyme. Furthermore
we also demonstrate a reversible mechanism of regulation of functional activity of Plasmodium
falciparum glutathione S-transferase via GSH induced dissociation of functionally inactive tetramer
into active dimers.
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Background
Development of resistance to the drugs used for prophy-
laxis and treatment of malaria makes the identification
and characterization of novel drug targets necessary [1,2].
Glutathione S-transferases (GSTs1; EC 2.5.1.18) form a
family of phase II detoxification enzymes and are present
in virtually all organisms. GSTs catalyze the nucleophilic
addition of the tripeptide glutathione to a large variety of
nonpolar compounds, thereby neutralizing their elec-
trophilic sites and rendering the products more water sol-
uble [3]. These products can be more easily excreted,
usually as a part of the mercapturic acid pathway [4]. GSTs
can furthermore detoxify lipid peroxidation products
[5,6] and serve as carrier proteins, so called ligandins, of
certain organic molecules, which lead to the inactivation
and immobilization of these compounds [4]. Other func-
tions include the detoxification of hydroperoxides and the
isomerization of specific metabolites (like prostaglandin
H and 13- cis retinoic acid), reduction of dehydroascor-
bate and transfer of thiols [7] contributing to cellular sig-
naling, regulation of transcription and stress response [8].
In cancer chemotherapy, the ability of GST to produce
reactive metabolites has been exploited to target tumors
that overexpress particular transferases [9].
On the basis of sequence similarity, immunological cross
reactivity and substrate specificity, the cytosolic GSTs have
been grouped into at least 13 classes: alpha, mu, pi, theta,
sigma, kappa, omega, lambda, phi, tau, delta, zeta, and
dehydroascorbate reductase (DHAR) [4,8,10-13].
Although the recognition of glutathione is conserved
among different classes, the active site residues involved
in glutathione binding vary from tyrosine in alpha, mu
and pi classes (mammals) to serine in theta and zeta
(ubiquitous), phi and tau (plants), and delta (insects)
classes or cysteine in omega (mammals & insects), beta
(bacteria) and lambda classes as well as in DHAR (plants)
[13].
GST of the malarial parasite Plasmodium falciparum repre-
sents a novel GST isoform, which cannot be assigned to
any of the known GST classes and constitutes more than
1% of the total cellular protein of the parasite [14,15].
PfGST shares highest sequence similarities with pi-class
GSTs from Dirofilaria immitis and  Onchocerca volvolus
(~35% identity). GST activity has been reported in all Plas-
modium species studied so far as well as in all intraerythro-
cytic stages of the parasite [16]. Furthermore GST activity
was shown to increase in chloroquine resistant parasites
under drug pressure [17]. Ferriprotoporphyrin IX, which
is produced in large quantities during the digestion of
hemoglobin by the parasite, has been characterized as
uncompetitive inhibitor of PfGST [14]. A pharmacologic
inhibition of PfGST is likely to impair the peroxidase, con-
jugation and heme binding activity of the enzyme. This –
together with the unique structural features of the enzyme
– makes PfGST, a most promising antimalarial drug target.
Conventionally the canonical GSTs are homo- or hetero-
dimeric proteins with each subunit consisting of a thiore-
doxin like domain I fused to an all α-helical domain II [8].
The active site is located at the cleft between the two
domains, consisting of two binding sites: the G-site which
binds reduced glutathione and the more variable H-site,
which can accommodate a variety of substrates [18]. The
H-site of PfGST differs significantly from that of its human
counterpart in being more accessible to solvent molecules
and amphiphilic inhibitors [18]. Aim of the present study
was to investigate the role of GSH in tetramer-dimer tran-
sition of PfGST, as well as in modulation of functional
properties of the enzyme together with structural, activity
and stability characterstics of the enzyme. Using size
exclusion chromatography and protein cross-linking as
well as fluorescence and CD spectroscopy in combination
with enzyme activity assays we studied this unique feature
of PfGST in detail. The structural and functional character-
ization of PfGST does contribute to our understanding of
the parasites' biology; the evolution of GSTs and to tar-
geted drug development against malaria.
Results and discussion
PfGST is stabilized as a tetramer
We carried out detailed studies on the structural and func-
tional properties of PfGST. Figure 1A shows the overex-
pression and purification of PfGST, which had the
expected molecular mass of about 26 kDa and a purity of
about 95%. The quaternary structure of PfGST was ana-
lyzed by SEC and glutaraldehyde cross-linking. On the
Superdex™ 200 column the protein showed a single peak
with a retention volume of 13.7 mL which corresponds to
a molecular mass of 104 kDa, as calculated from the val-
ues obtained for the protein standards (Figure 1B). This
suggests that the PfGST is indeed present as a tetramer.
This observation was further confirmed by the glutaralde-
hyde cross-linking of PfGST, which showed the presence
of a cross-linked protein band of a molecular mass of
about 104 kDa corresponding to the tetramer of the
enzyme (Figure 1B, inset). These results confirm previous
experiments, which showed that recombinant PfGST
forms under native conditions non-covalently linked
higher aggregates corresponding to 98% to tetramers [19].
To our knowledge PfGST is the only enzyme of the GST
family, which is present as a tetramer rather than a dimer.
Glutathione binding to PfGST modulates the conversion of 
inactive tetramer to active dimer
GSTs catalyze the general reaction GSH + R-X → GSR + H-
X. GST brings the hydrophobic or amphiphilic substrate
into close proximity with GSH and activates the sulfhydryl
group of GSH thereby allowing the nucleophilic attack onBMC Structural Biology 2007, 7:67 http://www.biomedcentral.com/1472-6807/7/67
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the electrophilic substrate [20]. All GSTs are highly spe-
cific towards GSH as the thiol substrate. GSH is bound in
an extended conformation to the enzyme at the G-site via
a network of specific polar interactions between the
tripeptide and a number of protein moieties in domain I
of one subunit and one or two amino acid residues in
domain II of the other subunit of the dimer. Hence the
dimer of the enzyme is the active conformation. As all
GSTs for which this catalytic mechanism has been
described are dimers we wanted to study if GSH binds to
the tetrameric protein and if this tetramer is functionally
active.
The binding of GSH to PfGST can be investigated by mon-
itoring the intrinsic tryptophan fluorescence of the
enzyme. The substrate binding results in partial quench-
ing of the fluorescence due to direct interactions between
the bound substrate and the indole fluorophore of the
tryptophan moiety [19,21]. We monitored the tryptophan
fluorescence of the PfGST tetramer incubated with
increasing concentrations of GSH. Quenching of the tryp-
tophan fluorescence intensity was observed at GSH con-
centrations between 0 to 0.8 mM (Figure 2A). Further
increase in GSH concentration did not lead to any further
quenching of fluorescence. However, a maximum of only
about 20% quenching of the tryptophan signal was
observed under these conditions. No alteration in the
emission wavelength maxima of the tryptophan fluores-
cence was observed in the presence of GSH. These obser-
vations collectively suggest that in presence of GSH the
PfGST tetramer undergoes structural change.
A very interesting result was obtained when we studied the
effect of GSH binding on the oligomeric structure of the
enzyme. Figure 2B shows the SEC profiles of the PfGST
tetramer after incubation with increasing concentration of
GSH. With increasing concentrations of GSH, two popu-
lations of the enzyme, one corresponding to the tetramer
(retention volume 13.7 mL) and the other one corre-
sponding to the dimer (retention volume 15.0 mL; molec-
ular mass about 52 kDa) were observed. Furthermore,
with increasing concentrations of GSH an enhancement
in the area under the peak corresponding to the dimer
along with a concomitant decrease in that corresponding
to the tetramer were observed. At GSH concentrations ≥
0.7 mM only a single peak corresponding to the dimeric
protein was observed. This was further confirmed by the
appearance of a cross-linked protein band of about 52
kDa (Figure 1B, inset). Furthermore, this GSH dependent
tetramer to dimer transition was found to be independent
of the enzyme concentration (data not shown). These
observations demonstrate that GSH binding to the PfGST
tetramer induces a dissociation of the tetramer into dim-
ers and that in the presence of higher GSH concentrations
a GSH-stabilized dimer is obtained.
As GSH was shown to induce dissociation of the native
PfGST tetramer into dimers we carried out activity assays
in presence of increasing concentrations of GSH to see
which configuration, dimer or tetramer, was functionally
active. Figure 2A shows the functional activity of the
PfGST tetramer in the presence of increasing concentra-
Overexpression of PfGST in E. coli and purification of the  recombinant protein over Ni-NTA agarose Figure 1
Overexpression of PfGST in E. coli and purification of 
the recombinant protein over Ni-NTA agarose. A. 
SDS-PAGE analysis of cell lysate showing overexpression of 
PfGST and the purified protein. Lanes 1–4 represent molecu-
lar weight markers, supernatant of un-induced culture lysate, 
supernatant of induced culture lysate and purified protein, 
respectively. B. Molecular weight andsubunit structure of 
PfGST dimer and tetramer. SEC profileof (a) dimeric PfGST; 
obtained by incubation of protein with 2 mM GSH and run 
with buffer containing 2 mM GSH and (b) tetrameric PfGST; 
incubated and run with buffer not containing GSH on a 
Superdex™ 200 10/300 GL column at pH 8.0 and 25°C. The 
column was calibrated with standard molecular weight mark-
ers: Glucose oxidase (160 kDa), albumin (66 kDa), ovalbumin 
(43 kDa), ribonuclease A (13.7 kDa) and aprotinin (6.5 kDa). 
The curves have been displaced on Y-axis for presentation. 
Inset shows the SDS-PAGE profile of glutaraldehyde cross-
linked PfGST protein samples. Lanes 1–4 represent molecu-
lar weight markers, uncross-linked native PfGST, glutaralde-
hyde cross-linked dimeric PfGST and tetrameric PfGST 
protein samples, respectively.
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Effect of GSH on oligomeric status and enzymatic activity of PfGST Figure 2
Effect of GSH on oligomeric status and enzymatic activity of PfGST. A. Quenching of tryptophan fluorescenceinten-
sity and enzymatic activity of tetrameric PfGST withincreasing concentrations of GSH. In the figure, solid and hollow squares 
denote data for enzymatic activity and fluorescence, respectively. B. SEC profile of tetrameric PfGST incubated with increasing 
concentrations of GSH for 2 h at 25°C and run in the same GSH containing buffer. In the figure, a-f represent curves for tetra-
meric PfGST incubated with 0, 0.1, 0.2, 0.4, 0.6 and 2.0 mM GSH, respectively. The curves have been displaced on Y-axis for 
presentation. Inset shows the percent population of dimeric (solid squares) and tetrameric (hollow squares) species of PfGST 
with increasing concentration of GSH based on the data obtained from the curves displayed in the main figure.
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tions of GSH. An exponential increase in enzymatic activ-
ity of PfGST was observed at GSH concentrations between
0 and 0.7 mM. However, further increase in GSH concen-
tration did not lead to further enhancement in activity.
The results demonstrate that the conditions for attain-
ment of maximal activity, namely saturation of GSH bind-
ing to the PfGST tetramer as well as complete dissociation
into dimers all occur at the same GSH concentration. This
demonstrates that the dimer and not the tetramer of
PfGST is the functionally active form of the enzyme. The
fact that the increase in activity is directly paralleled by the
dissociation of the tetramer indicates that the Km values
determined do not simply reflect the affinity of GSH to
the active enzyme but at the same time induce major
changes in quaternary structure resulting in active
enzyme. This is the first report for any GST where an alter-
ation in oligomeric structure and not just small conforma-
tional change are observed upon GSH binding.
In direct comparison with PfGST we studied the effect of
GSH on the oligomeric status of human GST. Figure 3
shows the SEC profiles of human GST in presence and
absence of GSH. For human GST a single peak with a
retention volume of 15.1 mL corresponding to a molecu-
lar mass of about 52 kDa was observed which clearly rep-
resents the dimeric protein. For the enzyme sample
incubated with GSH and run in presence of GSH no shift
in retention volume from the column was observed. This
was further confirmed by cross-linking of the eluted peaks
(Figure 3 inset). This demonstrates that human GST is
present as a dimer under physiological conditions and
binding of GSH to the human GST dimer does not affect
the oligomeric status of the enzyme.
From the recently reported crystal structure of PfGST, it
has been deduced that in absence of ligands two biologi-
cal dimers form a tetramer [18]. In the tetramer the
homodimers are interlocked with each other by a loop
interacting with the substrate-binding site (residues 113–
120). Upon binding of S-hexylglutathione, this loop
undergoes rearrangement. The changed course of residues
113–120 in the liganded enzyme prevents locking of the
dimers (19). A similar process is likely to take place upon
GSH binding to the enzyme. The oligomerization of
dimer into tetramer can be only a consequence and not
the cause of the loss of affinity for GSH as the tetramer for-
mation can be triggered by the structural change in the G-
site of the enzyme in the absence of GSH.
The GSH-induced dissociation of the PfGST tetramer is a 
reversible process
It has been reported that PfGST shows good stability and
constant specific activity only when it is stored at ≥ 1 mM
GSH [21]. The specific activity of the enzyme stored in 10
mM GSH drops to 50% in a few minutes after SEC in
absence of GSH or when the enzyme is stored in buffer
where GSH is absent [21]. However, no reason for this
partial or complete inactivation of PfGST has been given
so far. Our results indicate that GSH is essential for the
conversion of enzymatically inactive tetramer into active
dimer. It might thus be possible that the tetramer-dimer
conversion of PfGST is a reversible process, which is mod-
ulated by GSH. To study this hypothesis two sets of exper-
iments were carried out. Firstly the tetrameric PfGST
incubated with 2 mM GSH was loaded on a Superdex™
200 column and was run with buffer, which did not con-
tain GSH. Figure 4A summarizes the results of this study.
A SEC profile containing two populations, dimer and
tetramer, of enzyme was observed under these conditions
(Figure 4A(e)). This suggests that a significant population
(about 75%) of the enzymatically active dimer is con-
verted into inactive tetramer under these conditions and
this is what was reflected in the activity profile where only
about 30% activity was observed for the sample obtained
after SEC (Figure 4B). In the second experiment, the GSH-
stabilized enzymatically active dimer was dialyzed against
the buffer in which GSH was absent. The dialyzed protein
sample was loaded on the Sephadex S-200 column after 4
and 24 h of dialysis. Figure 4A(c, d) summarizes the
Effect of GSH on oligomeric status of human GST Figure 3
Effect of GSH on oligomeric status of human GST. 
SEC profile of human GST. Curve "a" represent hGST incu-
bated and run with buffer containing 2 mM GSH, while curve 
"b" represent hGST incubated and run with buffer not con-
taining GSH. The curves have been displaced on Y-axis for 
presentation. Inset shows the SDS-PAGE profile of glutaral-
dehyde cross-linked hGST protein samples. Lanes 1–4 repre-
sent molecular weight markers, uncross-linked native hGST, 
glutaraldehyde cross-linked hGST incubated with GSH and 
hGST incubated without GSH protein samples, respectively.
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results. For the 4 h dialyzed sample, the presence of both
the dimer and the tetramer in a ratio of about 1:3 was
observed. However, after 24 h of dialysis only the tetra-
meric enzyme species was observed. The analysis of the
enzymatic activity of these two samples showed about
28% and 0% activity, respectively (Figure 4B). These stud-
ies clearly demonstrate that the GSH-induced tetramer to
dimer conversion of PfGST is a reversible process with the
equilibrium shifting to either side due to the presence or
the absence of GSH.
Stability of PfGST tetramer and dimer against pH-, 
GdnHCl- and urea-induced denaturation
The effect of changing pH values on the structural features
of the dimeric and tetrameric species of PfGST was stud-
ied. Figure 5A shows the changes in secondary structure of
dimeric and tetrameric PfGST with varying pH. For the
PfGST dimer, the secondary structure was found to be sta-
ble between pH 5.0 and 8.0 as no alteration in secondary
structure of the protein was observed. However, decrease
in pH below 5.0 or increase in pH above 8.0 resulted in
denaturation of the enzyme as indicated by a significant
loss in secondary structure. At pH 4.0 or below and pH
10.0, almost complete loss of secondary structure was
observed. For the PfGST tetramer, a sigmoidal dependence
of the loss of secondary structure on the pH value was
observed. Between pH 10.0 and 6.0 no alteration was
determined. However, decrease in pH below 6.0 resulted
in loss of secondary structure. Interestingly, for the PfGST
tetramer even at a pH as low as 3.0, only a partial loss of
secondary structure of about 50% was observed suggest-
ing only partial unfolding of the enzyme at low pH.
The pH dependent studies demonstrate that unlike the
dimer which is denatured at alkaline pH, the PfGST
tetramer is resistant to alkaline pH. Both the tetramer and
the dimer show susceptibility to acidic pH, the tetramer is
however more stable under these conditions. Taken
together these observations demonstrate that the PfGST
tetramer is more stable than the dimer towards pH
induced denaturation, which is likely to be due to stronger
ionic interactions present in the tetrameric conformation.
The comparative unfolding and stability characteristics of
PfGST tetramer and dimer were studied by monitoring the
GdnHCl-induced changes in the structural properties of
the proteins. To study the changes in the secondary and
tertiary structure induced by GdnHCl, far-UV CD and
tryptophan fluorescence studies were carried out. A mini-
mum time of about 2 h was found to be sufficient for
achieving equilibrium under any of the denaturing condi-
tions studied. Figure 5B summarizes the effect of increas-
ing concentrations of GdnHCl on the CD ellipticity at 222
nm and tryptophan emission maxima of the PfGST
tetramer and dimer. For both conformations of the
enzyme, a sigmoidal loss of the CD signal at 222 nm and
a shift in the emission wavelength maxima of the tryp-
tophan fluorescence from 328 nm to 353 nm was
observed. Furthermore, the changes in tryptophan fluo-
rescence and the secondary structure of the proteins were
found to be concomitant with respect to GdnHCl concen-
tration. However, the GdnHCl concentration over which
the transition was observed was different for the two
forms of the enzyme. For the PfGST dimer, the transition
occurred between 1.0 and 4.0 M GdnHCl, with C1/2 for the
transition being 2.5 M GdnHCl. For the PfGST tetramer
Deciphering the reversibility of the tetramer-dimer transition Figure 4
Deciphering the reversibility of the tetramer-dimer 
transition. A. SEC profile of PfGST. Curves a-e represent 
tetrameric PfGST, dimeric PfGST, dimeric PfGST dialysed for 
4 h in buffer devoid of GSH, dimeric PfGST dialysed for 24 h 
in buffer devoid of GSH, dimeric PfGST loaded on the col-
umn equilibrated and run with buffer without GSH. The 
curves have been displaced on Y-axis for presentation. B. 
Enzymatic activity assay of the eluted peaks. In the figure, 
bars a-e represents data for the peaks described in 4A.
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the transition was observed between 2.5 and 4.0 M Gdn-
HCl, with C1/2 for the transition being 3.5 M GdnHCl.
The comparative unfolding and stability characteristics of
the PfGST tetramer and dimer with urea were studied by
monitoring the urea-induced changes in the structural
properties of the proteins. Figure 5C summarizes the effect
of increasing concentrations of urea on the CD ellipticity
at 222 nm and the tryptophan emission maxima of PfGST
tetramers and dimers. For both conformations, a similar
sigmoidal loss of the CD signal at 222 nm and a shift in
the emission wavelength maxima of the tryptophan fluo-
rescence from 328 nm to 353 nm was observed for CD
and fluorescence spectroscopy, respectively. According to
this data, a C1/2 of about 5.5 M urea was found to be asso-
ciated with the unfolding of both the PfGST tetramer and
dimer.
These results demonstrate that the PfGST tetramer has sig-
nificantly higher stability against GdnHCl denaturation as
compared to the PfGST dimer. However, with respect to
urea denaturation the tetramer and the dimer showed
similar stability. These observations along with the pH
stability studies suggest that the higher stability of the
pH-, GdnHCl- and urea- induced unfolding of dimeric and tetrameric PfGST at pH 8.0 and 25°C Figure 5
pH-, GdnHCl- and urea- induced unfolding of dimeric and tetrameric PfGST at pH 8.0 and 25°C. A. Effects of the 
pH on the CD signal at 222 nm for the dimeric (solidsquares) and tetrameric (hollow squares) PfGST. The data is presented as 
percentage with the value observed for enzyme at pH 8.0 taken as 100%. B Effect of increasing GdnHCl concentrations on the 
CD ellipticity at 222 nm and the tryptophan emission wavelength maxima of dimeric and tetrameric PfGST. C. Effect of increas-
ing urea concentrations on the CD ellipticity at 222 nm and the tryptophan emission wavelength maxima of dimeric and tetra-
meric PfGST. In the panel B and C, solid squares, solid circles, hollow squares and hollow circles represent data for CD of the 
dimers, fluorescence of the dimers, CD of the tetramers and fluorescence of the tetramers, respectively. The CD data has 
been presented as percentage with the value observed in the absence of denaturant (GdnHCl or urea) taken as 100%. The 
experimental details are mentioned in the Methods section.
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tetramer of PfGST as compared to the dimer is probably
due to the presence of stronger ionic interactions in this
conformation of enzyme.
Conclusion
The glutathione S-transferase of the malarial parasite Plas-
modium falciparum is the first GST for which a GSH
induced tetramer-dimer transition has been described.
Interestingly, the surrounding GSH levels in a physiologi-
cal concentration range of 0–0.7 mM regulate this transi-
tion. Until now the determination of GSH levels in
malarial parasites has been restricted to late trophozoites,
which represent the largest blood stage form and are thus
accessible to studies. Meierjohann et al., described a varia-
tion in GSH levels between different strains [22]. For
PfDd2 they measured 134 nmol/1010 cells, for Pf3D7 67
nmol/1010 cells. Assuming that a parasitized erythrocyte
has 90 fL (90 × 10-15 L) and 30 fL (corresponding to 1/3 of
the host cell compartment as described in Atamna and
Ginsburg [23]) of the cell is represented by the tropho-
zoite parasite, 1010 parasite cells would have a volume of
30 × 10-5 L which is equal to 300 μL. 134 nmol/300 μL
corresponds to 447 μM for PfDd2. For Pf3D7 a value of
223 μM can be calculated. In FCBR-strain, Luersen et al.,
found a GSH concentration of 0.42 mM [24]. Atamna and
Ginsburg measured a GSH concentration of 790 nmol/
1010 cells in the strain FCR3, corresponding to 2.6 mM.
This is by a factor of 10 higher than measured in the 3D7
strain. All these data indicate that the GSH concentrations
may vary considerably between different strains. Further-
more, the reliable determination of intraparasitic GSH
concentrations remains challenging – particularly due to
the limited material and the complex isolation and wash-
ing procedures required. These are also the reasons why
GSH levels throughout the complex life cycle of Plasmo-
dium in man and mosquitoes have not yet been studied
although they might vary considerably [25,26]. Taking
into account GSH concentrations between 223 μM and
2.6 mM (see above) as well as the fact that GSH has not
yet been determined in most of the parasite stages, a phys-
iological role of PfGST activity regulation by GSH in the
micromolar range should be seriously considered.
It is thus possible that PfGST is produced and – depending
on the surrounding GSH concentration – present as inac-
tive but more stable tetramer. With increasing GSH con-
centrations the enzyme becomes active, with decreasing
GSH concentrations it tetramerises again (Figure 6) and
this reversible transition regulates the functional activity
of PfGST. Under conditions of oxidative stress in the par-
asite, GSH levels can be depleted [25] and this would pre-
vent the dissociation of PfGST leading to accumulation of
inactive tetramer. Other regulatory principles including
low molecular weight ligands, post-translational modifi-
cations or protein-protein interactions might further con-
tribute to the modulation of this phenomenon. Since
PfGST currently represents one of the most attractive anti-
malarial drug targets and the reversible changes in the oli-
gomerization state of the protein is likely to reflect a novel
principle of GST regulation, we will address this phenom-
enon in further studies.
Methods
Materials
All chemicals used in the study were purchased from
Sigma-Aldrich Chemical Co., USA, and were of highest
purity available. The hGST from human placenta was also
obtained from Sigma. The water used for all studies was of
triple distilled grade. Superdex™ 200 10/300 GL column
was purchased from GE Healthcare Biosciences, USA,
while Ni-NTA agarose was from Qiagen.
Protein expression and purification
Recombinant PfGST was overexpressed in E. coli M15 cells
and purified as described earlier [14]. The ESI-MS and
SDS-PAGE of the purified PfGST protein showed that the
preparation was more than 95% pure. The protein was
dialyzed against 100 mM potassium phosphate buffer, pH
8.0 containing 1 mM EDTA. Two different buffer systems
were used- containing or not containing 2 mM GSH.
Size exclusion chromatography
Gel filtration experiments were carried out on a Super-
dex™ 200 10/300 GL column (manufacturer's exclusion
limit 600 kDa for proteins) on an ÄKTA-FPLC (GE Health
Schematic overview of PfGST tetramer-dimer transition with  respect to GSH binding, activity and stability Figure 6
Schematic overview of PfGST tetramer-dimer transition with 
respect to GSH binding, activity and stability.
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Care Biosciences). The column was equilibrated and run
with 100 mM potassium phosphate buffer, pH 8.0 con-
taining 1 mM EDTA, with a flow rate of 0.3 mL/min at
25°C. For GSH treated protein samples, the column was
equilibrated and run with the above-mentioned buffer
containing desired concentrations of GSH.
Chemical cross-linking
The protein samples, at a concentration of 50 μg/mL, were
used for cross-linking studies. An aliquot of 25% (w/v)
glutaraldehyde was added to obtain a final glutaraldehyde
concentration of 1%. The samples (2 mL) were stirred for
30 min at room temperature followed by quenching of
the cross-linking reaction by the addition of 2 μL of β-
mercaptoethanol. After incubation for 20 min, 3 μL of
10% aqueous sodium deoxycholate was added. The pH of
the reaction mixtures was lowered to 2–2.5 by the addi-
tion of orthophosphoric acid, which resulted in precipita-
tion of the cross-linked proteins. After centrifugation, the
obtained precipitates were re-dissolved and the molecular
mass of the cross-linked products was determined by 10%
SDS-PAGE.
Enzymatic activity
PfGST activity using GSH and CDNB as substrates was
determined spectrophotometrically at 340 nm on the
basis of the extinction coefficient for the product S-(2, 4-
dinitrophenyl) glutathione (ε340 nm = 9.6 mM -1cm-1). The
assay mixture (1 mL) contained 2.0 μM PfGST enzyme
and 1 mM GSH in 100 mM potassium phosphate buffer,
pH 8.0, 1 mM EDTA. The reaction was started by addition
of 0.5 mM CDNB. One unit of GST activity was defined as
the conjugation of 1 μmol of CDNB with GSH per minute
at 25°C [14]. The data was recorded with a Perkin-Elmer
Lambda 25 UV/Vis spectrophotometer at 25°C.
Fluorescence spectroscopy
Fluorescence spectra were recorded with a Perkin-Elmer
LS50B spectrophotometer in a 5 mm path length quartz
cell. 2.0 μM protein was used for the studies. The samples
were excited at 285 nm and the emission spectra were
recorded in the wavelength range of 300–400 nm. Spec-
tral scans were repeated thrice and the average was taken.
The excitation and emission slits were kept as 8 and 6 nm
respectively. Data was recorded at 25°C.
Far- ultraviolet circular dichroism
Far- UV CD measurements were made with a Jasco J-810
spectropolarimeter calibrated with ammonium(+)-10-
camphor sulphonate. CD spectra were measured at an
enzyme concentration of 2 μM with a 1 mm cell at 25°C.
In a typical experiment 3 spectral scans were taken. The
values obtained were normalized by subtracting the base-
line recorded for the buffer having the same concentration
of denaturant and/or GSH under identical conditions.
pH denaturation
Protein (2 μM) was dissolved in 10 mM citrate/glycine/
hepes buffer (containing 1 mM EDTA) of varying pH
(from 2.0 to 10.0) in the absence or presence of GSH and
was incubated for 2 h at room temperature (pH of the
solution maintained) before the measurements were
made.
GdnHCl and urea denaturation
Protein (2 μM) was dissolved in 100 mM potassium phos-
phate buffer, pH 8.0 containing 1 mM EDTA in the
absence or presence of increasing concentration of Gdn-
HCl/urea with or without GSH. It was incubated for 2 h at
room temperature, before the measurements were made.
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